Table of Contents Table of Contents
Previous Page  529 / 1024 Next Page
Information
Show Menu
Previous Page 529 / 1024 Next Page
Page Background

Multicenter study

Prospective

Inoperable T1/T2 NSCLC

N=60

Period: 2003-2005

SBRT

Dose: 45 Gy at 15 Gy/fx

Grade 3 toxicity: 21%

Local control 96%

OS: 65%

Baumann et al. Radiotherapy and Oncology 88 (2008) 359–367